Filing Details

Accession Number:
0001161697-24-000375
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-23 17:00:13
Reporting Period:
2024-08-21
Accepted Time:
2024-08-23 17:00:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1292636 S David Tierney 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2024-08-21 15,000 $4.01 363,874 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2024-08-21 15,000 $20.10 348,874 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Acquisiton 2024-08-22 15,000 $0.00 15,000 $4.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
188,931 2025-01-02 No 4 M Direct
Footnotes
  1. Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
  2. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $20.00 to $20.485 per share.
  3. Options vested in three annual tranches beginning on January 2, 2019.